(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






1302 Result: medical

Lucintel Forecasts Antimicrobial Coating Market to Reach $5 Billion by 2025

May 07th, 2021

Dallas, TX / CRWE PRESS RELEASE / May 07, 2021 - According to the recent study the Antimicrobial Coating Market is projected to reach an estimated $5 billion by 2025 from $3.5 billion in 2019, at a CAGR of 6.2% from 2020 to 2025. Growth in this marke. Read more

Lucintel Forecasts 3D Printing Materials Market to Reach $4 Billion by 2025

May 04th, 2021

Dallas, TX / CRWE PRESS RELEASE / May 05, 2021 - According to the recent study the 3D Printing Materials is projected to reach an estimated $4 billion by 2025 from $1.6 billion in 2019, at a CAGR of 17% from 2020 to 2025. Growth in thi. Read more

MasterStream ERP Helps MAXAIR Automate Their Quoting In Response To Covid-19 Demand

April 27th, 2020

IRVINE, CA / CRWE PRESS RELEASE / April 27, 2020 / MasterStream ERP (www.masterstreamerp.com), the makers of leading quote-to-cash automation software for telecom providers, master agents and agents, today announced that it is joining the fight with . Read more

Crown Equity Holdings Inc., a Vertically Integrated Global Media and Financial Services Company, Announces New Chairman of the Board

June 27th, 2018

Las Vegas, NV / CRWE PRESS RELEASE / June 27, 2018 / Crown Equity Holdings Inc. (OTC PINK: CRWE) is pleased to announce today that Steven A. Cantor has been elected by its Board to serve as Chairman of its Board of Directors. Mr. Cantor will succe. Read more

IBrands Acquires Colorado Real Estate And Shovel-Ready Cannabis Construction Project With Long-Term Tenant

May 09th, 2018

DALLAS, TX / CRWE PRESS RELEASE / May 9, 2018 - iBrands Corporation, Inc. (OTC PINK: IBRC) ("the Company"), a diversified holdings company, announces that it has acquired Durango Warehouse LLC., holder of 38 acres of arable land in Ignacio, Colorado.. Read more

Shire's First Prescription Eye Drop, Xiidra(TM) (lifitegrast ophthalmic solution) 5% Is Now Available in the U.S.

August 29th, 2016

Xiidra is the onlyprescription eye drop approved by the U.S. FDA for the treatment of both signs and symptoms of dry eye disease Resources are available to support patients seeking information regarding coverage and savings offers Xiidra is t. Read more

Nymox's New Phase 3 Long-Term U.S. Results For Prostate Enlargement Drug Fexapotide Show

August 29th, 2016

1. Dramatic Decrease in Prostate Cancer and 2. Major Reduction in Need For BPH Prostate Surgery HASBROUCK HEIGHTS, N.J. / CRWE PRESS RELEASE / August 29, 2016 - Nymox Pharmaceutical Corporation (NASDAQ:NYMX) lead drug fexapotide which has been . Read more

New Long-Term Data Reinforce Safety Benefits of the World's Smallest Pacemaker

August 28th, 2016

Results Featured at ESC 2016 Demonstrate Consistent, Sustained Safety and Effectiveness for the Medtronic Micra TPS DUBLIN and ROME / CRWE PRESS RELEASE / AUGUST 28, 2016 - In the largest and longest clinical evaluation of leadless pacing patients. Read more

ViewRay's MRIdian System Receives Japanese Regulatory Approval (Shonin)

August 15th, 2016

Expands MRI-Guided Radiation Therapy Access to World’s Third Largest Market CLEVELAND / CRWE PRESS RELEASE / August 15, 2016 – ViewRay, Inc. (Nasdaq: VRAY)announced today that the company received Shonin approval from the Japanese. Read more

Pluristem Receives Positive Feedback from FDA and Gears Up for Phase III Trial of PLX-PAD in Critical Limb Ischemia

August 02nd, 2016

- CLI is a severe unmet medical need whose treatment addresses a $12 billion global market - Multinational study to be conducted in U.S. and Europe - Estimated trial enrollment of approximately 250 patients - Primary endpoint for BLA will be time . Read more

EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammation and Pain in Cataract Surgery Patients

August 01st, 2016

WALTHAM, Mass. / CRWE PRESS RELEASE / Aug. 01, 2016 — EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing produ. Read more

ONIVYDE(R) Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas who have Progressed Following Gemcitabine based Therapy

July 25th, 2016

The positive opinion is based on a pivotal Phase 3 study showing that ONIVYDE combined with chemotherapy significantly increased overall survival (OS) in patients with metastatic pancreatic cancer after previous gemcitabine based therapy Zug, Swit. Read more

Transgenomic Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorp

July 20th, 2016

LabCorp’s DNA Testing for Long QT Syndrome, a Congenital Heart Rhythm Disorder Associated with Potentially Lethal Arrhythmias, is Enhanced by TBIO’s Intellectual Property OMAHA, NE / CRWE PRESS RELEASE / July 20, 2016 - Transgenom. Read more

Chronos Therapeutics Acquires Pre-clinical Programmes From Shire

July 20th, 2016

Expands Pipeline With Novel CNS Assets in a Transformative Deal Oxford, UK / CRWE PRESS RELEASE / July 20, 2016 - Chronos Therapeutics Ltd (Chronos), the private biotech company focused on ageing diseases, brain and nervous system disorders, today. Read more

SWISS Launches Revenue Service with State-of-the-Art Bombardier C Series Aircraft

July 15th, 2016

CS100 aircraft enters service as C Series program gains 127 orders in the first half of 2016 to increase total firm orders to 370 CS300 aircraft on track for first delivery to airBaltic scheduled for the fourth quarter of 2016 M. Read more

Load More Content